Inactive Instrument

Insiders Celldex Therapeutics, Inc. Nasdaq

Equities

US15117B1035

Insiders

Unlock all the news: Be the first to know and act before the market!

Celldex Therapeutics Insider Sold Shares Worth $1,586,844, According to a Recent SEC Filing	06-11	MT
Celldex Therapeutics Insider Sold Shares Worth $525,873, According to a Recent SEC Filing	06-11	MT
Celldex Therapeutics Insider Sold Shares Worth $1,579,353, According to a Recent SEC Filing	06-05	MT
Celldex Therapeutics Insider Sold Shares Worth $1,964,088, According to a Recent SEC Filing	06-05	MT
Celldex Therapeutics Insider Sold Shares Worth $1,191,775, According to a Recent SEC Filing	06-03	MT
Celldex Therapeutics Insider Sold Shares Worth $1,319,156, According to a Recent SEC Filing	06-03	MT
Celldex Therapeutics Insider Sold Shares Worth $1,298,384, According to a Recent SEC Filing	06-03	MT
Celldex Therapeutics, Inc. Announces Appointment of Rita Jain, M.D. to Board of Directors	23-02-16	CI
Insider Sell: Celldex Therapeutics	22-12-09	MT
Insider Sell: Celldex Therapeutics	22-08-19	MT
Insider Sell: Celldex Therapeutics	22-08-19	MT
Insider Sell: Celldex Therapeutics	22-08-17	MT
Insider Sell: Celldex Therapeutics	22-08-17	MT
Insider Sell: Celldex Therapeutics	22-08-15	MT
Celldex Therapeutics, Inc. Announces Board Appointments	22-06-16	CI
Insider Sell: Celldex Therapeutics	21-11-16	MT
Insider Sell: Celldex Therapeutics	21-11-03	MT
Insider Sell: Celldex Therapeutics	21-11-03	MT
Celldex Therapeutics, Inc. Promotes Freddy Jimenez, to the Newly Created Position of Senior Vice President and General Counsel	21-01-04	CI
Celldex Therapeutics, Inc. Appoints Diane C. Young as Senior Vice President, Chief Medical Officer, Effective July 8, 2019	19-06-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Celldex Therapeutics, Inc. Nasdaq

Equities

US15117B1035

Insiders

Filters